O

Open Orphan PLC
LSE:ORPH

Watchlist Manager
Open Orphan PLC
LSE:ORPH
Watchlist
Price: 10 GBX 5.26% Market Closed
Market Cap: 67.1m GBX

Wall Street
Price Targets

ORPH Price Targets Summary
Open Orphan PLC

There are no price targets for ORPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Open Orphan PLC Competitors:
Price Targets
2269
WuXi Biologics (Cayman) Inc
16% Upside
1521
Frontage Holdings Corp
20% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
35% Upside
TECH
Bio-Techne Corp
24% Upside
CTKB
Cytek Biosciences Inc
22% Upside
DIM
Sartorius Stedim Biotech SA
18% Upside
SLV
Selvita SA
20% Upside
HYFT
Immunoprecise Antibodies Ltd
149% Upside

Revenue
Forecast

Revenue Estimate
Open Orphan PLC

For the last 1 year the compound annual growth rate for Open Orphan PLC's revenue is 32%. The projected CAGR for the next 1 year is 43%.

32%
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Open Orphan PLC

Operating Income forecast
is not available for
Open Orphan PLC

Net Income
Forecast

Net Income Estimate
Open Orphan PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORPH's stock price target?
Not Available

ORPH doesn't have any price targets made by Wall Street professionals.

What is Open Orphan PLC's Revenue forecast?
Projected CAGR
43%

For the last 1 year the compound annual growth rate for Open Orphan PLC's revenue is 32%. The projected CAGR for the next 1 year is 43%.

Back to Top